Themis Medicare (THEMISMED) — concall transcript

📢 Key Event
Themis Medicare reported Q2 FY24 revenue of ₹104.78 crores, up 15% YoY, with 11.84% EBITDA margin and 10.8% PAT margin.

🔄 What Changed
Hospital segment growth accelerated to 20% YoY, trade business grew 35-40% YoY, and EBITDA margin improved to 11.84% in Q2 FY24.

🔮 What's Next
FY24/FY25 revenue growth expected to outpace H1, with EBITDA improvement contingent on resolving API manufacturing inefficiencies and market adoption of new products.

💡 Investor Takeaway
Growth is accelerating in both hospital and trade segments, but margin expansion depends on operational changes and market response to new launches.

Themis Medicare reported 15% YoY revenue growth to ₹104.78 crores in Q2 FY24 with 11.84% EBITDA margin and 10.8% PAT margin, driven by 20% hospital segment growth and 35-40% trade business expansion. Management highlighted strategic focus on hospital product launches, API business transfer to Themis Chemicals, and international expansion, while noting no planned capex or headcount increases. The Gujarat facility serves as an R&D center with contract manufacturing plans, and FY24/FY25 growth is expected to accelerate with EBITDA improvement anticipated from operational efficiencies.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THEMISMED ✨ Ask AI About This

About Themis Medicare Ltd (THEMISMED)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,142.96 Cr P/E: 28.6 ROE: 9.9% ROCE: 13.6% Div Yield: 0.40%

View full THEMISMED stock details →

📡 Get AI alerts when THEMISMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THEMISMED — Free

💡 Ask AI about this filing

"How will API business transfer impact Themis Chemicals' valuation?" "What specific triggers will drive EBITDA margin improvement in FY25?" "When will international expansion generate meaningful revenue?"

Ask AI Free →

📊 More THEMISMED filings

See all THEMISMED filings →

🔥 Also filed on 30 September 2023

PANAMAPET Panama Petrochem Ltd concall transcript M&M Mahindra & Mahindra Ltd concall transcript SBIN State Bank of India concall transcript ETERNAL Eternal Ltd concall transcript BAJFINANCE Bajaj Finance Ltd concall transcript ASIANPAINT Asian Paints Ltd concall transcript

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THEMISMED files new disclosures

Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THEMISMED — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd